Divi's , global pharma firm inkadvanced inermediates pact

            Divi's Laboratories has signed of long - term advanced inermediates manufacturing and supply pact with a global pharma company and plans to invest at least $650 crore, from inernal accruals, on capacity expansions . in a filing on Friday, Divi's said it expects menaingful revenue contribution  from the agreement , It expects meaningfuyl revenue contribution from the agreement . It is planning for capacity addition at its manufacturing facilities with an estimated 650 tto 700 crore investment to be funded from internal accruals 

Comments

Post a Comment

Popular posts from this blog

RBI permits minors above 10 to operate bank account

                           The Reserve Bank of India (RBI) on Monday permitted banks to allow minors above the age of 10 years to open and operate savings/term deposit accounts independently. Minors of any age may be allowed to open and operate savings and term deposit accounts through his/her natural or legal guardian, RBI said in a circular addressed to commercial banks and cooperative banks. They may also be allowed to open such accounts with their mother as guardian.
Read more